NASDAQ:VTGN

Vistagen Stock at 63 Cents: The June Trial Readout Traders Are Watching
····

Vistagen Stock at 63 Cents: The June Trial Readout Traders Are Watching

Vistagen Therapeutics shares traded near $0.63 ahead of Monday’s Nasdaq open as investors awaited Phase 3 trial data for its lead anxiety drug, fasedienol. The company, valued at $26.6 million, expects topline results from the PALISADE-4 study this quarter. Vistagen will present at the Jefferies Healthcare Conference in New York June 2–4. The stock closed Friday at $0.630 on 654,000 shares traded.
June 1, 2026

Stock Market Today

  • FTSE 100 dips 0.7% as Iran halts US peace talks; oil prices surge
    June 1, 2026, 1:19 PM EDT. The FTSE 100 fell 0.7% to 10,338.95 on Monday following Iran's suspension of peace talks with the U.S. amid renewed conflict linked to Israel's Lebanon offensive. The FTSE 250 and AIM also declined. Brent crude oil prices jumped to $97.22 a barrel, responding to Iran's threats to block key shipping routes including the Strait of Hormuz. European markets also slipped, with Paris' CAC 40 down 0.5% and Frankfurt's DAX 40 falling 0.4%. In contrast, U.S. indexes were mixed. UK manufacturing expanded at its fastest pace in four years despite cost pressures linked to Middle East tensions. BP and Shell shares rose over 2% on the back of higher oil prices. Key global currencies and Treasury yields reflected heightened geopolitical risk and market caution.